MIR6891

Across TCGA pan-cancer cohorts, MIR6891 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MIR6891’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where MIR6891 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR6891 is over-expressed in tumor.

KIRC, COAD, and BLCA are the cancer types where MIR6891 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR6891 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	+0.240	<.001	7	view →
COAD	All	All	+0.456	.006	6	view →
BLCA	Male	IV	+0.667	.040	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

MIR6891–KIRC

Open the KIRC breakdown →